Citigroup’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-47,849
Closed -$436K 6291
2025
Q2
$436K Buy
47,849
+4,250
+10% +$31.3K ﹤0.01% 3710
2025
Q1
$347K Sell
43,599
-42,194
-49% -$309K ﹤0.01% 3875
2024
Q4
$466K Buy
85,793
+16,687
+24% +$102K ﹤0.01% 3878
2024
Q3
$499K Buy
69,106
+26,208
+61% +$240K ﹤0.01% 3729
2024
Q2
$466K Sell
42,898
-293,575
-87% -$3.76M ﹤0.01% 3438
2024
Q1
$6.31M Buy
336,473
+212,110
+171% +$4.89M ﹤0.01% 1551
2023
Q4
$2.69M Sell
124,363
-52,210
-30% -$1.03M ﹤0.01% 2004
2023
Q3
$3.63M Buy
176,573
+108,814
+161% +$3.14M ﹤0.01% 1602
2023
Q2
$3.19M Sell
67,759
-66,103
-49% -$3.29M ﹤0.01% 1809
2023
Q1
$5.62M Buy
133,862
+60,361
+82% +$2.6M ﹤0.01% 1445
2022
Q4
$2.8M Sell
73,501
-78,756
-52% -$3.01M ﹤0.01% 1806
2022
Q3
$5.96M Buy
152,257
+50,926
+50% +$1.97M ﹤0.01% 1454
2022
Q2
$3.27M Buy
101,331
+33,826
+50% +$1.13M ﹤0.01% 1772
2022
Q1
$2.23M Sell
67,505
-99,629
-60% -$3.75M ﹤0.01% 2278
2021
Q4
$7.11M Buy
167,134
+114,318
+216% +$4.79M ﹤0.01% 1606
2021
Q3
$2.34M Sell
52,816
-62,122
-54% -$2.85M ﹤0.01% 2411
2021
Q2
$6.53M Buy
114,938
+30,932
+37% +$2.19M ﹤0.01% 1698
2021
Q1
$6.29M Buy
84,006
+51,907
+162% +$4.26M ﹤0.01% 1639
2020
Q4
$2.78M Buy
32,099
+16,842
+110% +$1.24M ﹤0.01% 2548
2020
Q3
$933K Sell
15,257
-37,091
-71% -$1.88M ﹤0.01% 3331
2020
Q2
$2.18M Sell
52,348
-10,748
-17% -$390K ﹤0.01% 2718
2020
Q1
$1.81M Sell
63,096
-34,330
-35% -$1.99M ﹤0.01% 2575
2019
Q4
$7.03M Buy
97,426
+33,396
+52% +$4.11M 0.01% 1748
2019
Q3
$8.98M Buy
64,030
+15,763
+33% +$2.64M 0.01% 1475
2019
Q2
$8.84M Buy
48,267
+8,960
+23% +$1.53M 0.01% 1490
2019
Q1
$6.25M Sell
39,307
-40,886
-51% -$5.92M 0.01% 1611
2018
Q4
$7.68M Buy
80,193
+23,529
+42% +$2.69M 0.01% 1459
2018
Q3
$8M Buy
56,664
+8,094
+17% +$1.25M 0.01% 1445
2018
Q2
$7.6M Buy
48,570
+19,086
+65% +$3M 0.01% 1488
2018
Q1
$4.75M Sell
29,484
-25,833
-47% -$4.39M ﹤0.01% 1817
2017
Q4
$9.11M Buy
55,317
+16,291
+42% +$1.58M 0.01% 1361
2017
Q3
$2.43M Sell
39,026
-7,049
-15% -$554K ﹤0.01% 2452
2017
Q2
$3.67M Sell
46,075
-99,260
-68% -$7.18M ﹤0.01% 1990
2017
Q1
$10.3M Sell
145,335
-91,218
-39% -$5.34M 0.01% 1112
2016
Q4
$12.1M Buy
236,553
+107,680
+84% +$5.08M 0.01% 1065
2016
Q3
$5.93M Buy
128,873
+120,322
+1,407% +$4.9M 0.01% 1513
2016
Q2
$258K Sell
8,551
-10,831
-56% -$361K ﹤0.01% 4264
2016
Q1
$622K Buy
19,382
+11,583
+149% +$408K ﹤0.01% 3890
2015
Q4
$455K Sell
7,799
-9,845
-56% -$488K ﹤0.01% 3958
2015
Q3
$747K Buy
17,644
+7,667
+77% +$472K ﹤0.01% 3357
2015
Q2
$728K Buy
9,977
+935
+10% +$60.1K ﹤0.01% 3383
2015
Q1
$454K Sell
9,042
-8,614
-49% -$370K ﹤0.01% 3835
2014
Q4
$647K Buy
17,656
+17,455
+8,684% +$651K ﹤0.01% 3607
2014
Q3
$6K Buy
+201
New +$5.82K ﹤0.01% 6501

Other funds holding SAGE